BioLife Solutions BLFS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -18.3%— | —— | —— | —— | |
| EBITDA margin | -15.9%-16.0pp | 0.1%— | —— | —— | |
| Returns | |||||
| Return on invested capital | -5.4%-3.8pp | -1.6%— | —— | —— | |
| Efficiency | |||||
| Asset turnover | 0.2×+0.1× | 0.2×— | —— | —— | |
| Liquidity | |||||
| Current ratio | 5.9×+1.4× | 4.5×+1.7× | 2.9×-0.2× | 3.1×+0.2× | |
| Quick ratio | 4.6×+1.0× | 3.7×+1.4× | 2.2×-0.1× | 2.3×0.0× | |
| Cash ratio | 1.4×-1.5× | 2.9×+2.1× | 0.8×+0.4× | 0.4×-1.2× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×+0.1× | |
| Debt-to-assets | 0×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -6.4×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $7.64+0.9% | $7.57-1.9% | $7.72-8.7% | $8.46-31.9% | |
| Valuation | |||||
| Market capitalization | $1.25B+33.1% | $1.2B+64.5% | $732.02M-6.0% | $778.34M-49.9% | |
| Enterprise value | $1.24B+38.1% | $1.14B+54.3% | $737.98M-8.0% | $802.58M-46.8% | |
| Price / sales | 12.5×+0.5× | 16.1×— | —— | —— | |
| Price / book | 3.6×+0.7× | 3.5×+1.3× | 2.2×0.0× | 2.1×-1.1× | |
| EV / sales | 13.4×+1.0× | 15.3×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioLife Solutions's profit margins?
- BioLife Solutions (BLFS) runs a 66.9% gross margin and a -16.7% operating margin, with a -68.7% net margin.
- Where do BioLife Solutions's ratios come from?
- Every ratio is computed from BioLife Solutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
